10X Genomics' GAAP loss for 9M 2021 was $39.774 million, down 3.2 times from $127.158 million in the prior year. Revenue increased 85.9% to $346.96 million from $186.627 million a year earlier.
10X Genomics' GAAP loss for 9M 2021 was $39.774 million, down 3.2 times from $127.158 million in the prior year. Revenue increased 85.9% to $346.96 million from $186.627 million a year earlier. 
investors.10xgenomics.com
English (US) 